Cargando…

Advances in stromal cell therapy for management of Alzheimer’s disease

Deposition of misfolded proteins and synaptic failure affects the brain in Alzheimer’s disease (AD). Its progression results in amnesia and cognitive impairment. Absence of treatment is due to excessive loss of neurons in the patients and the delayed effects of drugs. The enhanced pluripotency, prol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srivastava, Rashi, Li, Aidong, Datta, Tirtharaj, Jha, Niraj Kumar, Talukder, Salehikram, Jha, Saurabh Kumar, Chen, Zhe-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576849/ https://www.ncbi.nlm.nih.gov/pubmed/36267273 http://dx.doi.org/10.3389/fphar.2022.955401

Ejemplares similares

Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects
por: Pritam, Pingal, et al.
Publicado: (2022)

Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
por: Ye, Feng, et al.
Publicado: (2023)

Implications of Microorganisms in Alzheimer’s Disease
por: Yadav, Pardeep, et al.
Publicado: (2022)

Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease
por: Das, Sabya Sachi, et al.
Publicado: (2023)

Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer’s and Parkinson’s Diseases
por: Javed, Hayate, et al.
Publicado: (2023)

Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19
por: Sharma, Charu, et al.
Publicado: (2021)

Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
por: Hashiesh, Hebaallah Mamdouh, et al.
Publicado: (2021)

Unravelling the Therapeutic Potential of Botanicals Against Chronic Obstructive Pulmonary Disease (COPD): Molecular Insights and Future Perspectives
por: Mitra, Sicon, et al.
Publicado: (2022)

Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease
por: Jana, Ankit, et al.
Publicado: (2022)

p38 MAPK and PI3K/AKT Signalling Cascades inParkinson’s Disease
por: Jha, Saurabh Kumar, et al.
Publicado: (2015)

Emerging Therapies in the Management of Advanced-Stage Gastric Cancer
por: Kumar, Vivek, et al.
Publicado: (2018)

CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope
por: Karn, Vamika, et al.
Publicado: (2022)

Homology Modelling, Molecular Docking and Molecular Dynamics Simulation Studies of CALMH1 against Secondary Metabolites of Bauhinia variegata to Treat Alzheimer’s Disease
por: Khare, Noopur, et al.
Publicado: (2022)

Phytotherapy for Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-analysis
por: Dutta, Tusheema, et al.
Publicado: (2022)

Microfluidic Platforms to Unravel Mysteries of Alzheimer’s Disease: How Far Have We Come?
por: Prasanna, Pragya, et al.
Publicado: (2021)

Anticancer Applications and Pharmacological Properties of Piperidine and Piperine: A Comprehensive Review on Molecular Mechanisms and Therapeutic Perspectives
por: Mitra, Sicon, et al.
Publicado: (2022)

Alzheimer's disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies
por: Jha, Niraj Kumar, et al.
Publicado: (2020)

Advances in Multi-Functional Ligands and the Need for Metal-Related Pharmacology for the Management of Alzheimer Disease
por: Sharma, Abha, et al.
Publicado: (2018)

Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2
por: Mathur, Aanchal, et al.
Publicado: (2021)

Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin
por: Thomas, Shilu Deepa, et al.
Publicado: (2023)

Advances in Alzheimer’s disease’s pharmacological treatment
por: Conti Filho, Carlos Elias, et al.
Publicado: (2023)

β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19
por: Jha, Niraj Kumar, et al.
Publicado: (2021)

Comparative study of anti-angiogenic activities of luteolin, lectin and lupeol biomolecules
por: Ambasta, Rashmi K., et al.
Publicado: (2015)

Plant Products as Inhibitors of Coronavirus 3CL Protease
por: Mandal, Anirban, et al.
Publicado: (2021)

Epigenetic factors in breast cancer therapy
por: Mathur, Runjhun, et al.
Publicado: (2022)

Molecular Mechanism and Role of Japanese Encephalitis Virus Infection in Central Nervous System-Mediated Diseases
por: Yadav, Pardeep, et al.
Publicado: (2022)

Advances in the roles and mechanisms of lignans against Alzheimer’s disease
por: Han, Na, et al.
Publicado: (2022)

CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
por: Bhardwaj, Shanu, et al.
Publicado: (2021)

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
por: Li, Ke, et al.
Publicado: (2019)

An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
por: Indari, Omkar, et al.
Publicado: (2021)

The Emerging Role of Epigenetics in Metabolism and Endocrinology
por: Sibuh, Belay Zeleke, et al.
Publicado: (2023)

Oxidative Stress in Cancer Cell Metabolism
por: Arfin, Saniya, et al.
Publicado: (2021)

Differential Transcriptome Profiling Unveils Novel Deregulated Gene Signatures Involved in Pathogenesis of Alzheimer’s Disease
por: Singh, Himanshu Narayan, et al.
Publicado: (2022)

Molecular mechanisms of developmental pathways in neurological disorders: a pharmacological and therapeutic review
por: Jha, Niraj Kumar, et al.
Publicado: (2022)

Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study
por: Li, Weihao, et al.
Publicado: (2022)

Trilateral association of autophagy, mTOR and Alzheimer’s disease: Potential pathway in the development for Alzheimer’s disease therapy
por: Subramanian, Arunkumar, et al.
Publicado: (2022)

Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update
por: Cenini, Giovanna, et al.
Publicado: (2019)

Molecular basis of fluoride toxicities: Beyond benefits and implications in human disorders
por: Pal, Priyankar, et al.
Publicado: (2022)

Therapeutic potential of mGluR5 targeting in Alzheimer's disease
por: Kumar, Anil, et al.
Publicado: (2015)

A review on mitochondrial restorative mechanism of antioxidants in Alzheimer’s disease and other neurological conditions
por: Kumar, Anil, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dr7ke18jl27294o68k97v4se3a